
Work Here?
Industries
Data & Analytics
Biotechnology
Healthcare
Company Size
11-50
Company Stage
Early VC
Total Funding
$11M
Headquarters
San Francisco, California
Founded
2019
Probably Genetic offers free at-home genetic testing for people with rare diseases. Patients collect a DNA sample at home, mail it in, and receive physician-reviewed results with genetic counseling and a clinical genetic report. The company funds the tests itself and keeps the data; after de-identification, the aggregated data is sold to research institutions and pharmaceutical companies. Its goal is to help patients get timely diagnoses while funding the program through data-driven partnerships to advance rare-disease research.
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$11M
Above
Industry Average
Funded Over
2 Rounds
Unlimited Paid Time Off
Hybrid Work Options
Remote Work Options
Company Equity
Health Insurance
Dental Insurance
Parental Leave
Aus Österreich heraus den aktivsten HealthTech-Fonds Europas zu starten, ist eine Leistung, die sich Lucanus Polagnoli und sein Team auf die Segel, pardon, Fahnen, schreiben können: Doch seit 2023 investiert Calm/Storm Ventures nicht nur in Digital-Health-Startups, sondern hat auch einen eigenen Fonds für Startups aufgelegt, mit dem auch in Startups aus anderen Branchen investiert, solange diese von Österreicher:innen (mit-)gegründet wurden. „Mit insgesamt 17 Neu-Investments ist das Portfolio auf 75 Startup-Unternehmen gewachsen. Zusammen mit 21 Follow-On Transaktionen innerhalb des Portfolios wurden 2023 insgesamt über 4,5 Millionen Euro investiert“, so Calm/Storm-CEO Lucanus Polagnoli zu Trending Topics. Man würde besonders oft in so genannte Stealth-Startups investieren, also Jungfirmen, die noch gar nicht auf dem Markt sind. Ein Beispiel ist Mirror, das neue Startup der ehemaligen Gründer von Gorillas, Kagan Sümer und Ugur Samut. Wert wird auf Diversität gelegt; Die Hälfte der Teams, in die Calm/Storm investieret, sind divers, und 30% aller CEOs seien Frauen
The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.
scn2a foundation probably genetic partner to accelerate scn2a diagnosis. . “By increasing the ability to test for rare disorders, there will be a better opportunity to diagnose and treat patients with rare diseases. Lukas and his team are doing amazing work and we’re happy to help in any way we can” said Jason Curry, Founder of The SCN2A Foundation
Apbdrf is thrilled to announce that the APBD Research Foundation has partnered with Probably Genetic to increase access to genetic testing within its community.
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Biotechnology
Healthcare
Company Size
11-50
Company Stage
Early VC
Total Funding
$11M
Headquarters
San Francisco, California
Founded
2019
Find jobs on Simplify and start your career today